Sight Sciences Receivables 2021-2024 | SGHT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sight Sciences receivables from 2021 to 2024. Receivables can be defined as the total amount of collectibles for a company

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Sight Sciences receivables from 2021 to 2024. Receivables can be defined as the total amount of collectibles for a company

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$216.7B
Thermo Fisher Scientific (TMO)	$203.1B
Alcon (ALC)	$44.2B
Edwards Lifesciences (EW)	$44B
IDEXX Laboratories (IDXX)	$36.9B
DexCom (DXCM)	$35B
IQVIA Holdings (IQV)	$34.6B
Mettler-Toledo (MTD)	$27.3B
Waters (WAT)	$22.4B
STERIS (STE)	$21.8B
SONOVA HOLDING (SONVY)	$19.6B
Hologic (HOLX)	$14.4B
Fresenius Medical Care AG KGaA (FMS)	$13.6B
Penumbra (PEN)	$11.7B
Sysmex ADR (SSMXY)	$11.5B
Globus Medical (GMED)	$11.5B
Masimo (MASI)	$9.6B
Glaukos (GKOS)	$8.9B
Teleflex (TFX)	$8.1B
Integer Holdings (ITGR)	$4.8B
Inari Medical (NARI)	$4.7B
PROCEPT BioRobotics (PRCT)	$3.5B
Veracyte (VCYT)	$3.3B
Nihon Kohden (NHNKY)	$2.7B
TransMedics (TMDX)	$2.7B
LivaNova (LIVN)	$2.6B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
Integra LifeSciences Holdings (IART)	$1.7B
Alphatec Holdings (ATEC)	$1.5B